ALKEM.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally...

Stats
本日の出来高	228 807
平均出来高	234 815
時価総額	617.42B
EPS	INR49.76 ( 2024-02-09 )
次の収益日	( INR0 ) 2024-05-16
Last Dividend	INR10.00 ( 2023-08-09 )
Next Dividend	INR0 ( N/A )
P/E	39.26
ATR14	INR4.01 (0.08%)

ボリューム相関

長: 0.47 (neutral)

短: -0.47 (neutral)

Signal:(51.959) Neutral

Alkem Laboratories 相関

10 最も正の相関
MASPTOP50.NS	0.902
MAFANG.NS	0.885
BAJAJ-AUTO.NS	0.881
HARIOMPIPE.NS	0.876
MON100.NS	0.869
SETF10GILT.NS	0.868
DATAPATTNS.NS	0.868
MANINDS.NS	0.865
MOGSEC.NS	0.862
GTNTEX.NS	0.861

10 最も負の相関
MOHOTAIND.NS	-0.877
ROLTA.NS	-0.865
SECURKLOUD.NS	-0.864
SUMICHEM.NS	-0.861
RUSHIL.NS	-0.852
CLNINDIA.NS	-0.849
BAFNAPH.NS	-0.848
LICI.NS	-0.847
DPSCLTD.NS	-0.846
EASTSILK.NS	-0.841

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Alkem Laboratories 相関 - 通貨/商品

0.08
( neutral )

0.16
( neutral )

0.57
( weak )

0.50
( weak )

-0.84
( strong negative )

-0.80
( strong negative )

Alkem Laboratories 財務諸表

Annual	2022
収益:	INR115.99B
総利益:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
収益:	INR115.99B
総利益:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
収益:	INR105.12B
総利益:	INR62.29B (59.25 %)
EPS:	INR137.63

FY	2021
収益:	INR87.47B
総利益:	INR51.61B (59.00 %)
EPS:	INR132.57

Financial Reports:

No articles found.

Alkem Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR4.00 (N/A)	INR0 (N/A)	INR25.00 (N/A)	INR0 (N/A)	INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alkem Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.90 - low (29.79%) | Divividend Growth Potential Score: 5.48 - Stable (9.70%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR9.70	2016-03-18
Last Dividend	INR10.00	2023-08-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	INR177.70	--
Avg. Dividend % Per Year	0.71%	--
Score	2.84	--
Div. Sustainability Score	3.90
Div.Growth Potential Score	5.48
Div. Directional Score	4.69	--

Next Divdend (Est)
(2024-08-08)

INR8.69 Estimate 7.41 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.84

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR13.00	0.65%
2019	INR16.00	0.83%
2020	INR25.00	1.20%
2021	INR30.00	1.02%
2022	INR34.00	0.93%
2023	INR35.00	1.17%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
HERITGFOOD.NS	Dividend Junior	2023-08-14	Annually	23	0.44%
BIKAJI.NS	Dividend Junior	2023-06-08	Insufficient data to determine frequency	2	0.06%
RANEHOLDIN.NS	Dividend Junior	2023-07-27	Annually	21	0.95%
KOPRAN.NS	Dividend Junior	2023-09-07	Annually	5	1.18%
ESCORTS.NS	Dividend Junior	2023-06-30	Annually	28	0.21%
ALPHAGEO.NS	Dividend Junior	2023-09-22	Annually	18	2.07%
SYMPHONY.NS	Dividend Knight	2023-08-04	Semi-Annually	14	0.47%
NESCO.NS	Dividend Junior	2023-07-28	Annually	17	0.40%
IDBI.NS	Dividend Junior	2023-07-06	Sporadic	27	0.48%
CERA.NS	Dividend Junior	2023-06-20	Annually	17	0.39%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.125	1.500	7.51	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.163	1.500	9.30	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	18.58	1.000	4.23	4.23	[3 - 30]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.597	1.000	3.38	3.38	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.63	8.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	38.78	1.000	6.18	0	[1 - 100]
returnOnEquityTTM	0.163	2.50	9.55	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.882	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	10.16	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0466	1.000	-1.336	0	[0.1 - 0.5]
Total Score				5.48

Alkem Laboratories

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.